Press Enter

Share with your friends and help them crack UPSC!

Or Share on

Answer

Correct Option is as there is a lack of information about the precision of the vaccine and its safety

Solution: Refer to the first paragraph of the passage which mentions, “The regulator did not wait for sufficient safety and efficacy data to be collected and did not share information about the clinical trials before granting approval” we can infer option (a). Hence correct choice is option (a).

Get access to all of our verified questions